Interventional Oncology Market Research Report 2021-2031
The Interventional Oncology Market is expected to register a CAGR of 8.2% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The report is segmented by Product (Embolization Devices, Ablation Devices, Support Devices). The report further presents analysis based on the Procedure (Thermal Tumor Ablation, Non-Thermal Tumor Ablation, Transcatheter Arterial Chemoembolization, Transcatheter Arterial Radioembolization or Selective Internal Radiation Therapy, Transcatheter Arterial Embolization or Bland Embolization). The report is segmented by Cancer Type (Liver Cancer, Lung Cancer, Bone Cancer, Kidney Cancer, Other Cancers). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Interventional Oncology Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Interventional Oncology Market Segmentation
Product- Embolization Devices
- Ablation Devices
- Support Devices
- Thermal Tumor Ablation
- Non-Thermal Tumor Ablation
- Transcatheter Arterial Chemoembolization
- Transcatheter Arterial Radioembolization or Selective Internal Radiation Therapy
- Transcatheter Arterial Embolization or Bland Embolization
- Liver Cancer
- Lung Cancer
- Bone Cancer
- Kidney Cancer
- Other Cancers
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Interventional Oncology Market Growth Drivers- Rising Cancer Incidence: Interventions oncology is driven by one of the critical factors through the increased incidence of cancer, especially global cancer rates which call for an urgent requirement for better and less invasive treatment strategies. Procedures under interventional oncology include ablation and embolization that are targeted therapies with minimum trauma to the patient and recovery time. This increased prevalence contributes to awareness among providers and patients, as well as investment in innovative technologies and techniques. It encompasses both an aging population and lifestyle factors that drive cancer rates, which means the demand for interventional oncology solutions has expanded steadily to position this field for significant growth and development over the next several years.
- Advancements in Technology: Technological advancements are revolutionizing the interventional oncology market with more effectiveness and accuracy in cancer treatment methods. For example, better visualization of tumors through high resolution MRI and CT, targeted interventions, and more success rates in cancer treatment methods through high resolution MRI and CT. Minimally invasive tools such as radiofrequency ablation and cryoablation devices are receiving advanced types to improve patient outcomes and reduce recovery time. Moreover, robotics and artificial intelligence have made procedures smoother, aided in decision making, and ensured proper planning before intervention. All these technological advancements will make treatments more efficient and more applicable in more fields of varied kinds of cancers to thus promote further development in the field and change the outlook of patient care in interventional oncology.
- Growing Awareness: There is a huge impact of rising awareness about interventional oncology on the growth of its market. Increasing knowledge among medical professionals and patients of minimally invasive treatment modalities is driving the uptake and acceptance of these procedures. Educating programs, medical conferences, and electronic media that have spread information concerning the advantages of interventional oncology, such as reduced recovery time and fewer complications compared to other surgeries, is also a driving force that boosts market growth. The patient advocacy groups can also assist in generating awareness and inform patients about their treatment alternatives. Awareness increased and continues to do so, which fuels the demand for new treatments, encourages the active engagement of stakeholders, and enhances the cancer care landscape as a whole.
- AI and Machine Learning: AI and machine learning change the interventional oncology market by enhancing diagnosis accuracy and personalizing treatment. Enhanced analysis of images thus improves the detection and characterization of tumors. Predictive analytics helps in making personalized recommendations based on data from the patient. Automated clinical workflows improve efficiency within healthcare settings. Real-time decision support technologies can be used during interventional oncological procedures for improved safety and outcomes. In addition, AI allows for the stratification of patients. It reveals those most likely to be benefited by specific interventions. That technology, when used in electronic health records, optimizes clinical trials and encourages a more involved patient-all contributing toward better patient care and outcomes with interventional oncology.
- Minimally Invasive Techniques: Minimally invasive techniques have long provided revolutionary alternatives in the interventional oncology market, as effective alternatives to traditional surgeries. Procedures like radiofrequency ablation, microwave ablation, and transarterial chemoembolization allow the proper targeting of tumors with a considerable decrease in recovery time and less pain post-surgery. This improves patient safety and results in faster returns to daily activity. Advanced imaging technology ensures precise targeting of lesions, while reducing trauma through endoscopy and catheter-guided interventions. Interest in the overall treatment strategies for oncology continues to grow as a minimally invasive option based on the trend for personalised, patient-centered care.
- Enhanced Decision Support: Greater decision support in the interventional oncology market employs sophisticated algorithms and AI to gain insights at the right time of procedure performance. These systems analyze patient data and image analysis results to provide recommendations to assist clinicians in decision making. The combined clinical guidelines with historical outcomes streamline treatment plans specific to the individual patient, thereby making the procedures more precise for targeting tumors with fewer complications. Further, these technologies offer opportunities for multidisciplinary collaboration and ensure that all healthcare providers are on the same page as regards the best course of action. Overall, better decision support contributes to improved patient outcomes and boosts the confidence of medical teams.
- Expanding Application: Expanding applications of interventional oncology are revolutionizing the market, and increasingly treatable tumors are increasing. Techniques that are originally applied to liver cancers are now efficaciously being used for treatment against lung, kidney, and bone cancers, among others. This diversification is due to improvements made in imaging and technology that improve precision during treatment. Additionally, interventional methods such as ablation and embolization are increasingly being combined with systemic therapies to provide comprehensive treatment options. As more clinical evidence on these applications begins to surface, health care providers are likely to take up interventional oncology as an ordinary treatment, and that will lead to further market growth and better care of patients with various cancers.
- Collaboration with pharmaceutical companies: The interventional oncology companies are collaborating with pharmaceutical companies to establish some very big market opportunities. Here, such collaboration integrates innovative interventional techniques with pharmaceutical therapies such as immunotherapy and targeted agents, which improves the effectiveness of the treatment and makes more holistic care options available for patients. Such collaborations are on the mechanisms to develop combination therapies with a focus to streamline the treatment protocols and work towards improving clinical outcomes. Moreover, collaborative research efforts may lead to the discovery of new therapies and better stratification of the patient population. Over time, such collaborations are likely to push interventional oncology to new horizons, which may further have an impact on patients and health care organizations by providing better targeted and effective therapeutic management.
- Integration with Telemedicine: Telemedicine and remote monitoring revolutionize the interventional oncology market in more ways than one with improvement of access to care for patients. These technologies lead to pre- and post-procedure consultations where advice is given to patients by specialists irrespective of distance. The remote monitoring tool has enabled healthcare providers to track the progression of patients, manage complications promptly, and intervene to address issues as timely as possible. Telehealth platforms also support educating the patient and engaging them in better understanding the available treatment options. The advancement of these technologies will be an integral part of the improvement in the outcome of patient care and increased workflows and delivery of interventional oncology services to various populations.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Interventional Oncology Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Interventional Oncology Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Embolization Devices segment, by type, dominated the market in 2023.
Players operating in the market are BTG International Ltd, HealthTronics, Inc, IceCure Medical Ltd, IMBIOTECHNOLOGIES LTD, Medtronic, MedWaves, Inc., Sanarus, and Teleflex Incorporated
Expanding Application act as a opportunity for growth of the market in forecast period.
North America region dominated the interventional oncology market in 2023.
The Interventional Oncology Market is estimated to witness a CAGR of 8.2% from 2023 to 2031
The major factors driving the interventional oncology market are:
1. Rising Cancer Incidence
2.Advancements in Technology
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Interventional Oncology Market - By Product
1.3.2 Interventional Oncology Market - By Procedure
1.3.3 Interventional Oncology Market - By Cancer Type
1.3.4 Interventional Oncology Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTERVENTIONAL ONCOLOGY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTERVENTIONAL ONCOLOGY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. INTERVENTIONAL ONCOLOGY MARKET - GLOBAL MARKET ANALYSIS
6.1. INTERVENTIONAL ONCOLOGY - GLOBAL MARKET OVERVIEW
6.2. INTERVENTIONAL ONCOLOGY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INTERVENTIONAL ONCOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. EMBOLIZATION DEVICES
7.3.1. Overview
7.3.2. Embolization Devices Market Forecast and Analysis
7.3.3. Radioembolic Agents Market
7.3.3.1. Overview
7.3.3.2. Radioembolic Agents Market Forecast and Analysis
7.3.4. Non-Radioactive Embolic Agents Market
7.3.4.1. Overview
7.3.4.2. Non-Radioactive Embolic Agents Market Forecast and Analysis
7.4. ABLATION DEVICES
7.4.1. Overview
7.4.2. Ablation Devices Market Forecast and Analysis
7.4.3. Radiofrequency (RF) Ablation Devices Market
7.4.3.1. Overview
7.4.3.2. Radiofrequency (RF) Ablation Devices Market Forecast and Analysis
7.4.4. Microwave Ablation Devices Market
7.4.4.1. Overview
7.4.4.2. Microwave Ablation Devices Market Forecast and Analysis
7.4.5. Cryoablation Devices Market
7.4.5.1. Overview
7.4.5.2. Cryoablation Devices Market Forecast and Analysis
7.4.6. Other Ablation Devices Market
7.4.6.1. Overview
7.4.6.2. Other Ablation Devices Market Forecast and Analysis
7.5. SUPPORT DEVICES
7.5.1. Overview
7.5.2. Support Devices Market Forecast and Analysis
7.5.3. Microcatheters Market
7.5.3.1. Overview
7.5.3.2. Microcatheters Market Forecast and Analysis
7.5.4. Guidewires Market
7.5.4.1. Overview
7.5.4.2. Guidewires Market Forecast and Analysis
8. INTERVENTIONAL ONCOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - PROCEDURE
8.1. OVERVIEW
8.2. PROCEDURE MARKET FORECASTS AND ANALYSIS
8.3. THERMAL TUMOR ABLATION
8.3.1. Overview
8.3.2. Thermal Tumor Ablation Market Forecast and Analysis
8.4. NON-THERMAL TUMOR ABLATION
8.4.1. Overview
8.4.2. Non-Thermal Tumor Ablation Market Forecast and Analysis
8.5. TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION
8.5.1. Overview
8.5.2. Transcatheter Arterial Chemoembolization Market Forecast and Analysis
8.6. TRANSCATHETER ARTERIAL RADIOEMBOLIZATION OR SELECTIVE INTERNAL RADIATION THERAPY
8.6.1. Overview
8.6.2. Transcatheter Arterial Radioembolization or Selective Internal Radiation Therapy Market Forecast and Analysis
8.7. TRANSCATHETER ARTERIAL EMBOLIZATION OR BLAND EMBOLIZATION
8.7.1. Overview
8.7.2. Transcatheter Arterial Embolization or Bland Embolization Market Forecast and Analysis
9. INTERVENTIONAL ONCOLOGY MARKET - REVENUE AND FORECASTS TO 2028 - CANCER TYPE
9.1. OVERVIEW
9.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
9.3. LIVER CANCER
9.3.1. Overview
9.3.2. Liver Cancer Market Forecast and Analysis
9.4. LUNG CANCER
9.4.1. Overview
9.4.2. Lung Cancer Market Forecast and Analysis
9.5. BONE CANCER
9.5.1. Overview
9.5.2. Bone Cancer Market Forecast and Analysis
9.6. KIDNEY CANCER
9.6.1. Overview
9.6.2. Kidney Cancer Market Forecast and Analysis
9.7. OTHER CANCERS
9.7.1. Overview
9.7.2. Other Cancers Market Forecast and Analysis
10. INTERVENTIONAL ONCOLOGY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Interventional Oncology Market Overview
10.1.2 North America Interventional Oncology Market Forecasts and Analysis
10.1.3 North America Interventional Oncology Market Forecasts and Analysis - By Product
10.1.4 North America Interventional Oncology Market Forecasts and Analysis - By Procedure
10.1.5 North America Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.1.6 North America Interventional Oncology Market Forecasts and Analysis - By Countries
10.1.6.1 United States Interventional Oncology Market
10.1.6.1.1 United States Interventional Oncology Market by Product
10.1.6.1.2 United States Interventional Oncology Market by Procedure
10.1.6.1.3 United States Interventional Oncology Market by Cancer Type
10.1.6.2 Canada Interventional Oncology Market
10.1.6.2.1 Canada Interventional Oncology Market by Product
10.1.6.2.2 Canada Interventional Oncology Market by Procedure
10.1.6.2.3 Canada Interventional Oncology Market by Cancer Type
10.1.6.3 Mexico Interventional Oncology Market
10.1.6.3.1 Mexico Interventional Oncology Market by Product
10.1.6.3.2 Mexico Interventional Oncology Market by Procedure
10.1.6.3.3 Mexico Interventional Oncology Market by Cancer Type
10.2. EUROPE
10.2.1 Europe Interventional Oncology Market Overview
10.2.2 Europe Interventional Oncology Market Forecasts and Analysis
10.2.3 Europe Interventional Oncology Market Forecasts and Analysis - By Product
10.2.4 Europe Interventional Oncology Market Forecasts and Analysis - By Procedure
10.2.5 Europe Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.2.6 Europe Interventional Oncology Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Interventional Oncology Market
10.2.6.1.1 Germany Interventional Oncology Market by Product
10.2.6.1.2 Germany Interventional Oncology Market by Procedure
10.2.6.1.3 Germany Interventional Oncology Market by Cancer Type
10.2.6.2 France Interventional Oncology Market
10.2.6.2.1 France Interventional Oncology Market by Product
10.2.6.2.2 France Interventional Oncology Market by Procedure
10.2.6.2.3 France Interventional Oncology Market by Cancer Type
10.2.6.3 Italy Interventional Oncology Market
10.2.6.3.1 Italy Interventional Oncology Market by Product
10.2.6.3.2 Italy Interventional Oncology Market by Procedure
10.2.6.3.3 Italy Interventional Oncology Market by Cancer Type
10.2.6.4 Spain Interventional Oncology Market
10.2.6.4.1 Spain Interventional Oncology Market by Product
10.2.6.4.2 Spain Interventional Oncology Market by Procedure
10.2.6.4.3 Spain Interventional Oncology Market by Cancer Type
10.2.6.5 United Kingdom Interventional Oncology Market
10.2.6.5.1 United Kingdom Interventional Oncology Market by Product
10.2.6.5.2 United Kingdom Interventional Oncology Market by Procedure
10.2.6.5.3 United Kingdom Interventional Oncology Market by Cancer Type
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Interventional Oncology Market Overview
10.3.2 Asia-Pacific Interventional Oncology Market Forecasts and Analysis
10.3.3 Asia-Pacific Interventional Oncology Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Interventional Oncology Market Forecasts and Analysis - By Procedure
10.3.5 Asia-Pacific Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.3.6 Asia-Pacific Interventional Oncology Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Interventional Oncology Market
10.3.6.1.1 Australia Interventional Oncology Market by Product
10.3.6.1.2 Australia Interventional Oncology Market by Procedure
10.3.6.1.3 Australia Interventional Oncology Market by Cancer Type
10.3.6.2 China Interventional Oncology Market
10.3.6.2.1 China Interventional Oncology Market by Product
10.3.6.2.2 China Interventional Oncology Market by Procedure
10.3.6.2.3 China Interventional Oncology Market by Cancer Type
10.3.6.3 India Interventional Oncology Market
10.3.6.3.1 India Interventional Oncology Market by Product
10.3.6.3.2 India Interventional Oncology Market by Procedure
10.3.6.3.3 India Interventional Oncology Market by Cancer Type
10.3.6.4 Japan Interventional Oncology Market
10.3.6.4.1 Japan Interventional Oncology Market by Product
10.3.6.4.2 Japan Interventional Oncology Market by Procedure
10.3.6.4.3 Japan Interventional Oncology Market by Cancer Type
10.3.6.5 South Korea Interventional Oncology Market
10.3.6.5.1 South Korea Interventional Oncology Market by Product
10.3.6.5.2 South Korea Interventional Oncology Market by Procedure
10.3.6.5.3 South Korea Interventional Oncology Market by Cancer Type
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Interventional Oncology Market Overview
10.4.2 Middle East and Africa Interventional Oncology Market Forecasts and Analysis
10.4.3 Middle East and Africa Interventional Oncology Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Interventional Oncology Market Forecasts and Analysis - By Procedure
10.4.5 Middle East and Africa Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.4.6 Middle East and Africa Interventional Oncology Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Interventional Oncology Market
10.4.6.1.1 South Africa Interventional Oncology Market by Product
10.4.6.1.2 South Africa Interventional Oncology Market by Procedure
10.4.6.1.3 South Africa Interventional Oncology Market by Cancer Type
10.4.6.2 Saudi Arabia Interventional Oncology Market
10.4.6.2.1 Saudi Arabia Interventional Oncology Market by Product
10.4.6.2.2 Saudi Arabia Interventional Oncology Market by Procedure
10.4.6.2.3 Saudi Arabia Interventional Oncology Market by Cancer Type
10.4.6.3 U.A.E Interventional Oncology Market
10.4.6.3.1 U.A.E Interventional Oncology Market by Product
10.4.6.3.2 U.A.E Interventional Oncology Market by Procedure
10.4.6.3.3 U.A.E Interventional Oncology Market by Cancer Type
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Interventional Oncology Market Overview
10.5.2 South and Central America Interventional Oncology Market Forecasts and Analysis
10.5.3 South and Central America Interventional Oncology Market Forecasts and Analysis - By Product
10.5.4 South and Central America Interventional Oncology Market Forecasts and Analysis - By Procedure
10.5.5 South and Central America Interventional Oncology Market Forecasts and Analysis - By Cancer Type
10.5.6 South and Central America Interventional Oncology Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Interventional Oncology Market
10.5.6.1.1 Brazil Interventional Oncology Market by Product
10.5.6.1.2 Brazil Interventional Oncology Market by Procedure
10.5.6.1.3 Brazil Interventional Oncology Market by Cancer Type
10.5.6.2 Argentina Interventional Oncology Market
10.5.6.2.1 Argentina Interventional Oncology Market by Product
10.5.6.2.2 Argentina Interventional Oncology Market by Procedure
10.5.6.2.3 Argentina Interventional Oncology Market by Cancer Type
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INTERVENTIONAL ONCOLOGY MARKET, KEY COMPANY PROFILES
12.1. BTG INTERNATIONAL LTD.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. HEALTHTRONICS, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ICECURE MEDICAL LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. IMBIOTECHNOLOGIES LTD.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MEDTRONIC
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MEDWAVES, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. SANARUS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. TELEFLEX INCORPORATED
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. TERUMO CORPORATION
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. TROD MEDICAL
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. BTG International Ltd.
2. HealthTronics, Inc.
3. IceCure Medical Ltd
4. IMBIOTECHNOLOGIES LTD.
5. Medtronic
6. MedWaves, Inc.
7. Sanarus
8. Teleflex Incorporated
9. Terumo Corporation
10. Trod Medical
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For